Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET FORECAST 2022-2030

GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET FORECAST 2022-2030

The global clinical trials support services market was valued at $20702.63 million in 2021, and is expected to reach $40159.64 million by 2030, growing at a 7.65% CAGR during the forecast period, 2022-2030. The market study has also analyzed the impact of COVID-19 on the clinical trials support services market qualitatively and quantitatively.

GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET FORECAST 2022-2030

Global Clinical Trials Support Services Market by Phase (Phase I, Phase II, Phase III, Phase IV) Market by Sponsor (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Other Sponsors) Market by Service (Clinical Trial Site Management, Administrative Services, Patient Recruitment Management, Regulatory Services, Data Management, Other Services) by Geography

Request free sample

The global clinical trials support services market was valued at $20702.63 million in 2021, and is expected to reach $40159.64 million by 2030, growing at a 7.65% CAGR during the forecast period, 2022-2030. The market study has also analyzed the impact of COVID-19 on the clinical trials support services market qualitatively and quantitatively.

To know more about this report, request a free sample copy

A clinical trial is a research study in which various experiments or tests are performed on humans and animals, and researchers or investigators then examine the results. Clinical trials are classified into two types: interventional trials and observational studies. Support services are solutions or services provided to individuals or organizations to efficiently execute and complete tasks.

Clinical Trial Support Services Market

Read our latest blog on the Clinical Trials Support Services Market

Thus, clinical trial support services are those that aid in the optimization of the trial process. Support services make the trial process more efficient, from data management to data analysis. Key players such as IQVIA, Parexel, ICON PLC, KCR, PSI CRO, etc., provide various services such as clinical trial management services, site management services, data management services, biostatistics, etc.

Key growth enablers for the global clinical trials support services market are:

  • Rising prevalence of chronic disease & virus outbreaks
    • Environmental and lifestyle changes are both contributing to the rise in health-related issues. Numerous chronic diseases and conditions affect the elderly. Alzheimer’s disease and other dementias, arthritis, cancer, diabetes, heart disease, obesity, osteoporosis, tobacco-related conditions, irritable bowel syndrome, and other issues have become common and visible in the general population.
    • Spanish Flu hit the world in 1918 and lasted for two years. COVID-19 hit the world in 2020, and the virus is still surviving and mutating. Another virus known as Monkeypox was discovered in 2022, and an outbreak has been observed in Europe and North America.
  • Benefits of clinical trial support services

Key growth restraining factors are:

  • Availability of open-source/freeware software
    • There are open sources for sale on the market. Clinion CTMS by Clinion IT Services, Decentralized Clinical Trials by Medrio, ePRO/eCOA by Viedoc Technologies, StudyPal by Delve Health, and others are open-source software.
    • Some significant disadvantages to open-source software are security flaws, a lack of support, certification difficulties, etc. When additional security measures are not implemented, the risk of hacking and data breaches in open-source software increases. Open-source software does not receive the same level of support as proprietary software.
  • Stringent regulations

Global Clinical Trials Support Services Market | Top Trends

  • There has been an increase in the number of diseases worldwide. The patients are prescribed to use screening and specific treatments, among other things A screening test is performed to identify potential health problems in people who do not exhibit symptoms. The test is prescribed to detect the problem early so that it can be treated effectively and reduce the risk of disease spread.
  • With the lifestyle changes, new health-related issues have arisen, and a few viruses outbreaks such as COVID-19, Ebola, Monkeypox, etc. These issues have necessitated the development of vaccines and a few medical drugs to provide better and more efficient treatment.
  • Data management is expected to grow in the coming years. The primary goal of the data management process is to provide high-quality data to analysts while keeping errors and missing data to a minimum.

Market Segmentation – Phase, Service, and Sponsor –

Market by Phase:

  • Phase I
  • Phase II
  • Phase III
    • Phase III has emerged as the largest growing market in the clinical trials support services market, capturing 53.88% of the market share in 2021.
    • After completing Phase II clinical trials and receiving approval for Phase III clinical trials, the primary goal of the Phase III trial is to determine whether the treatment is safe and effective in a larger group.
    • A much larger group of people participate voluntarily in the Phase III clinical trial. These trials are frequently conducted in multiple locations across the country (or even around the world) at the same time. Local community hospitals and doctor’s offices are more likely to offer Phase III clinical trials.
  • Phase IV

Market by Service:

  • Clinical Trial Site Management
  • Administrative Services
  • Patient Recruitment Management
    • Patient Recruitment & Registry Services
    • Patient Retention
    • Other Patient Recruitment Management
  • Regulatory Services
  • Data Management
  • Other Services

Market by Sponsor:

  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies
    • Medical Devices is the fastest growing sponsor in the clinical trials support services market with a CAGR of 6.95%.
    • Medical device companies are another type of clinical trial sponsor. They provide the medical devices required for clinical trials. This method makes it simple to carry out clinical trials in the future.
    • Alcon, a medical device company that also sponsors the clinical trial, believes in the importance of independent ethical research conducted by qualified investigators.
  • Other Sponsors

Geographical Study based on Four Major Regions:

  • North America: The United States and Canada
  • Europe: The United Kingdom, Germany, France, Italy, Spain, Sweden, Denmark, Hungary, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Taiwan, Singapore, Thailand, Australia & New Zealand, and Rest of Asia-Pacific
    • Asia-Pacific is the fastest growing region in the clinical trials support services market, with a CAGR of 8.21%. The market is expanding because Asia is the most populous region, which benefits the clinical trial process by providing researchers with access to a large population of patients.
    • In clinical trials, researchers obtain high-quality data at a low cost compared to the United States and Europe, which benefits the clinical trial process.
    • Clinical trial costs are significantly lower in the Asia-Pacific region than in the United States and Western Europe.
  • Rest of World: Latin America, the Middle East & Africa

The major players in the global clinical trials support services market are:

  • IQVIA
  • Parexel
  • Syneos Health
  • Labcorp Drug Development
  • Clinipace
  • Charles River Laboratories Inc
  • Medpace

Key strategies adopted by some of these companies: 

  • In April 2022, Advanced Clinical announced the opening a new office in Zug, Switzerland, as part of its continued expansion into Europe.
  • In January 2022, Charles River Laboratories International, Inc expanded its collaboration with SAMDI Tech Inc to address the throughput and sample preparation limitations of traditional MS screening methods by combining self-assembled monolayers and MALDI MS.
  • Syneos Health launched its Patient Voice Consortium in June 2021.

Report Synopsis:

Report Scope Details
Market Forecast Years 2022-2030
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue ($ Million)
Segments Analyzed Phase, Service, and Sponsor
Geographies Analyzed North America, Europe, Asia-Pacific, and Rest of World
Companies Analyzed

Advanced Clinical, Alcura, Charles River Laboratories Inc, Clinipace, CTI Clinical Trial and Consulting Services Inc, ICON PLC, IQVIA, KCR, Labcorp Drug Development, Medpace, Parexel, PSI CRO, Syneos Health, Worldwide Clinical Trials, WuXi AppTec

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • RISING PREVALENCE OF CHRONIC DISEASE & VIRUS OUTBREAKS
      • BENEFITS OF CLINICAL TRIAL SUPPORT SERVICES
    • KEY RESTRAINTS
      • AVAILABILITY OF OPEN-SOURCE/FREEWARE SOFTWARE
      • STRINGENT REGULATIONS
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON CLINICAL TRIALS SUPPORT SERVICES MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
      • PERFORMANCE
      • EASE OF USE
      • SECURITY
      • COST-EFFECTIVENESS
    • REGULATORY FRAMEWORK
  2. MARKET BY PHASE
    • PHASE I
    • PHASE II
    • PHASE III
    • PHASE IV
  3. MARKET BY SPONSOR
    • PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
    • MEDICAL DEVICE COMPANIES
    • OTHER SPONSORS
  4. MARKET BY SERVICE
    • CLINICAL TRIAL SITE MANAGEMENT
    • ADMINISTRATIVE SERVICES
    • PATIENT RECRUITMENT MANAGEMENT
      • PATIENT RECRUITMENT & REGISTRY SERVICES
      • PATIENT RETENTION
      • OTHER PATIENT RECRUITMENT MANAGEMENT
    • REGULATORY SERVICES
    • DATA MANAGEMENT
    • OTHER SERVICES
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • SPAIN
        • ITALY
        • SWEDEN
        • DENMARK
        • HUNGARY
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • TAIWAN
        • SINGAPORE
        • THAILAND
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • MERGERS & ACQUISITIONS
      • PRODUCT LAUNCHES & DEVELOPMENTS
      • PARTNERSHIPS & AGREEMENTS
      • BUSINESS EXPANSIONS & DIVESTITURES
    • COMPANY PROFILES
      • ADVANCED CLINICAL
      • ALCURA
      • CHARLES RIVER LABORATORIES INC
      • CLINIPACE
      • CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
      • ICON PLC
      • IQVIA
      • KCR
      • LABCORP DRUG DEVELOPMENT
      • MEDPACE
      • PAREXEL
      • PSI CRO
      • SYNEOS HEALTH
      • WORLDWIDE CLINICAL TRIALS
      • WUXI APPTEC

LIST OF TABLES  

TABLE 1: MARKET SNAPSHOT – CLINICAL TRIALS SUPPORT SERVICES

TABLE 2: LIST OF PANDEMIC OUTBREAKS

TABLE 3: LIST OF OPEN-SOURCE SOFTWARE

TABLE 4: LIST OF PARTNERSHIPS

TABLE 5: LAUNCH OF MEDICAL DRUGS

TABLE 6: PROMISING ACQUISITIONS IN THE INDUSTRY

TABLE 7: REGULATORY FRAMEWORK

TABLE 8: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 9: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 10: GLOBAL PHASE I MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 11: GLOBAL PHASE I MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 12: GLOBAL PHASE II MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 13: GLOBAL PHASE II MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 14: GLOBAL PHASE III MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 15: GLOBAL PHASE III MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 16: GLOBAL PHASE IV MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 17: GLOBAL PHASE IV MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 18: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 19: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 20: GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 21: GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 22: GLOBAL MEDICAL DEVICE COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 23: GLOBAL MEDICAL DEVICE COMPANIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 24: GLOBAL OTHER SPONSORS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 25: GLOBAL OTHER SPONSORS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 26: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 27: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 28: GLOBAL CLINICAL TRIAL SITE MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 29: GLOBAL CLINICAL TRIAL SITE MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 30: GLOBAL ADMINISTRATIVE SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 31: GLOBAL ADMINISTRATIVE SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 32: GLOBAL PATIENT RECRUITMENT MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 33: GLOBAL PATIENT RECRUITMENT MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 34: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 35: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 36: GLOBAL PATIENT RECRUITMENT & REGISTRY SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 37: GLOBAL PATIENT RECRUITMENT & REGISTRY SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 38: GLOBAL PATIENT RETENTION MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 39: GLOBAL PATIENT RETENTION MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 40: GLOBAL OTHER PATIENT RECRUITMENT MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 41: GLOBAL OTHER PATIENT RECRUITMENT MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 42: GLOBAL REGULATORY SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 43: GLOBAL REGULATORY SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 44: GLOBAL DATA MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 45: GLOBAL DATA MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 46: GLOBAL OTHER SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 47: GLOBAL OTHER SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 48: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 49: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 50: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 51: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 52: LEADING PLAYERS OPERATING IN NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET

TABLE 53: NUMBER AND TYPES OF REGISTERED STUDIES

TABLE 54: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 55: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 56: LEADING PLAYERS OPERATING IN EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET

TABLE 57: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 58: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 59: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET

TABLE 60: REST OF WORLD CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 61: REST OF WORLD CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 62: LEADING PLAYERS OPERATING IN REST OF WORLD CLINICAL TRIALS SUPPORT SERVICES MARKET

TABLE 63: LIST OF MERGERS & ACQUISITIONS

TABLE 64: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 65: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 66: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: VALUE CHAIN ANALYSIS

FIGURE 6: KEY BUYING CRITERIA

FIGURE 7: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PHASE, IN 2021

FIGURE 8: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2030 (IN $ MILLION)

FIGURE 9: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2030 (IN $ MILLION)

FIGURE 10: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2030 (IN $ MILLION)

FIGURE 11: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2030 (IN $ MILLION)

FIGURE 12: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SPONSOR, IN 2021

FIGURE 13: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2030 (IN $ MILLION)

FIGURE 14: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2030 (IN $ MILLION)

FIGURE 15: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2030 (IN $ MILLION)

FIGURE 16: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2021

FIGURE 17: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2030 (IN $ MILLION)

FIGURE 18: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE SERVICES, 2022-2030 (IN $ MILLION)

FIGURE 19: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2030 (IN $ MILLION)

FIGURE 20: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PATIENT RECRUITMENT MANAGEMENT, IN 2021

FIGURE 21: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT & REGISTRY SERVICES, 2022-2030 (IN $ MILLION)

FIGURE 22: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RETENTION, 2022-2030 (IN $ MILLION)

FIGURE 23: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER PATIENT RECRUITMENT MANAGEMENT, 2022-2030 (IN $ MILLION)

FIGURE 24: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY SERVICES, 2022-2030 (IN $ MILLION)

FIGURE 25: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2030 (IN $ MILLION)

FIGURE 26: GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2030 (IN $ MILLION)

FIGURE 27: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 28: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 29: CANADA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 30: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 31: UNITED KINGDOM CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 32: GERMANY CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 33: FRANCE CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 34: SPAIN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 35: ITALY CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 36: SWEDEN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 37: DENMARK CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 38: HUNGARY CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 39: REST OF EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 40: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 41: CHINA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 42: JAPAN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 43: INDIA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 44: SOUTH KOREA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 45: TAIWAN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 46: SINGAPORE CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 47: THAILAND CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 48: AUSTRALIA & NEW ZEALAND CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 49: REST OF ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 50: REST OF WORLD CLINICAL TRIALS SUPPORT SERVICES MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)

FIGURE 51: LATIN AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 52: MIDDLE EAST & AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)

  1. MARKET BY PHASE
    • PHASE I
    • PHASE II
    • PHASE III
    • PHASE IV
  2. MARKET BY SPONSOR
    • PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
    • MEDICAL DEVICE COMPANIES
    • OTHER SPONSORS
  3. MARKET BY SERVICE
    • CLINICAL TRIAL SITE MANAGEMENT
    • ADMINISTRATIVE SERVICES
    • PATIENT RECRUITMENT MANAGEMENT
      • PATIENT RECRUITMENT & REGISTRY SERVICES
      • PATIENT RETENTION
      • OTHER PATIENT RECRUITMENT MANAGEMENT
    • REGULATORY SERVICES
    • DATA MANAGEMENT
    • OTHER SERVICES
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • SPAIN
        • ITALY
        • SWEDEN
        • DENMARK
        • HUNGARY
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • TAIWAN
        • SINGAPORE
        • THAILAND
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Frequently Asked Questions (FAQs):

    What is the worth of the global clinical trials support services market?

    The global clinical trials support services market was valued at $20702.63 million in 2021.

    Which region owned the largest market share in the global clinical trials support services market in 2021?

    North America owned the largest market share of 39.74% in the global clinical trials support services market in 2021.

    Which is the fastest-growing country in the global clinical trials support services market?

    India is the fastest-growing country in the global clinical trials support services market, with a CAGR of 9.42%.

    To request a free sample copy of this report, please complete the form below:

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now